Globenewswire
Search documents
NANO Nuclear Expands its Nuclear Policy Leadership Expertise with the Appointment of U.S. Government Veteran Sarah Lennon as its International Nuclear Policy Advisor
Globenewswire· 2026-02-20 13:30
Core Viewpoint - NANO Nuclear Energy Inc. has appointed Sarah Lennon as its International Nuclear Policy Advisor, aiming to enhance its engagement in nuclear energy policy and regulatory frameworks to support the development of its clean energy projects [1][4][8]. Company Overview - NANO Nuclear Energy Inc. is a North American advanced technology-driven nuclear energy company focused on becoming a commercially diversified and vertically integrated entity across five business lines: microreactor technologies, nuclear fuel fabrication, nuclear fuel transportation, nuclear applications for space, and nuclear industry consulting services [8][9]. Appointment of Sarah Lennon - Sarah Lennon brings three decades of experience in national security and nuclear energy policy, having served in various senior roles within the U.S. Government, including the Department of Energy (DOE) and the National Nuclear Security Administration (NNSA) [2][5]. - Her previous roles include Senior Policy Advisor for Strategic Planning at NNSA and Director for Bilateral and Multilateral Cooperation at DOE's Office of Nuclear Energy, where she advanced U.S. engagement on global nuclear energy and nonproliferation issues [3][5]. Strategic Importance - The appointment of Sarah Lennon is seen as a significant asset for NANO Nuclear as it seeks to engage with international stakeholders and advance its lead project, the KRONOS MMR™ modular microreactor energy system [4][8]. - The company emphasizes that her insights and leadership will strengthen its policy strategy and support the responsible development of its proprietary technologies [4][8]. Future Developments - NANO Nuclear is developing several advanced nuclear reactor products, including the KRONOS MMR™ Energy System, ZEUS™, and the portable LOKI MMR™, which are designed to provide clean energy solutions [9]. - The company is also working on establishing a domestic source for High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication through its subsidiary HALEU Energy Fuel Inc. (HEF) [11].
Kirby Corporation Announces New Director of the Board Tracy A. Embree
Globenewswire· 2026-02-20 13:30
HOUSTON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kirby Corporation ("Kirby") (NYSE: KEX) today announced the appointment of Tracy A. Embree as a new independent member of the Kirby Board of Directors effective February 16, 2026. She will stand for election at the annual meeting of the corporation in April of this year. Ms. Embree is the retired President of Otis Americas, a division of Otis Worldwide Corporation, and brings more than 25 years of global leadership experience across industrial operations, manufactu ...
Off The Hook Yachts Signs Definitive Agreement to Acquire the Apex Marine Group of Companies (APEX), Creating a Mega Service, Refurbishment & Sales Hub for Growing Global Customer Base
Globenewswire· 2026-02-20 13:30
Off The Hook YS Inc. Miami Supercenter Strategic move into physical global mega-destination site complements Off The Hook’s industry-leading AI-powered online marketplace, the largest of its kind for pre-owned boats in the U.S. Centralized hub to support the Company’s rapidly expanding inventory pipeline and international buyer network Wilmington, NC, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Off The Hook YS Inc. (NYSE American: OTH) (“Off The Hook Yachts” or “Off The Hook” or “the Company”), a vertically integ ...
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Globenewswire· 2026-02-20 13:30
PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced the adoption of a protocol amendment to its Phase 3 VERSATILE-003 clinical trial. The amendment includes PFS as an interim primary endpoint to support a potential accelerated approval pathway for PDS0101 in HPV16-positive recurrent and/or metastatic head and ...
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
Globenewswire· 2026-02-20 13:30
Core Viewpoint - CDT Equity Inc. has announced a strategic transaction to acquire a 20% equity stake in Sarborg Limited, enhancing collaboration and growth opportunities for both companies [1][3][4]. Group 1: Strategic Transaction - The acquisition formalizes and deepens the existing collaboration between CDT and Sarborg, which has already supported the evaluation of CDT's clinical assets through Sarborg's AI capabilities [2][3]. - The total consideration for the acquisition is $115 million, to be settled through the issuance of 598,005 new common stock in CDT and 109,978,918 pre-funded warrants, pending shareholder approval [5]. Group 2: Business Synergies - Sarborg's business focuses on using biological, chemical, and industrial signatures as a universal data language to identify and generate high-value opportunities, which aligns with CDT's focus on solid-form development [2][3]. - The transaction provides CDT shareholders with exposure to Sarborg's growth beyond pharmaceuticals, allowing for broader participation in sectors where signature analysis can be applied [4]. Group 3: Leadership Perspective - Dr. Andrew Regan, CEO of CDT, emphasized that acquiring a stake in Sarborg strengthens their relationship and aligns with a business whose innovative approach is complementary to CDT's own [5].
Rio2 to Present at BMO's Global Metals, Mining and Critical Minerals Conference and PDAC
Globenewswire· 2026-02-20 13:30
Core Insights - Rio2 Limited is participating in BMO's 35th Global Metals, Mining, and Critical Minerals Conference to discuss growth plans for the Fenix Gold Mine and the newly acquired Condestable Mine [1] - The presentation at the BMO Conference is scheduled for February 25, 2026, at 9:00 AM [1] - Rio2 will also participate in PDAC, with a presentation by Andrew Cox on March 2 at 10:10 AM [2] Company Overview - Rio2 Limited is a diversified producer of precious metals and copper, focusing on building and operating mines [3] - The company is currently producing gold at the Fenix Gold heap leach mine in Chile and copper/gold/silver at the Condestable underground mine in Peru [3] - Rio2 emphasizes high environmental standards and responsible development, aiming to exceed regulatory requirements [3]
Rio2 to Present at BMO’s Global Metals, Mining and Critical Minerals Conference and PDAC
Globenewswire· 2026-02-20 13:30
VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Rio2 Limited (“Rio2” or the “Company”) (TSX: RIO; OTCQX: RIOFF; BVL: RIO) is pleased to announce that its executive team lead by Alex Black, Executive Chairman of the Board, and Andrew Cox, President & CEO, will attend BMO’s 35th Global Metals, Mining, and Critical Minerals Conference next week in Hollywood, Florida, to discuss its future growth plans for the Fenix Gold Mine and the newly acquired Condestable Mine. Rio2 is set to present on Wedn ...
VCI Global Advances AI-Native Infrastructure Strategy with Formation of ROBODAX, Unifying Robotics Automation and Real-World Asset Digital Infrastructure
Globenewswire· 2026-02-20 13:24
Core Insights - VCI Global Limited has launched ROBODAX, a strategic platform initiative aimed at integrating its robotics automation and real-world asset digital infrastructure strategies into a unified execution architecture [1][2][4] Group 1: ROBODAX Initiative - The formation of ROBODAX signifies a structural shift towards an AI-native infrastructure operating model, integrating robotics automation, AI orchestration, tokenization architecture, and enterprise settlement capabilities [2][4] - ROBODAX is designed to link physical automation outputs with digital asset infrastructure, supporting monetization models that connect robotics-generated activities with tokenized commerce [3][5] - Although ROBODAX is not currently a revenue-generating product, it is expected to enhance the company's long-term infrastructure positioning and operational efficiency [4][6] Group 2: Company Strategy and Operations - The company operates a platform-based model that allows subsidiaries and affiliates to connect with centralized AI, data, governance, and capital allocation systems, promoting faster execution and scalable growth [7][8] - VCI Global maintains a diversified exposure across various sectors, including advisory, AI, digital infrastructure, energy, automotive, and consumer sectors, continuously evaluating opportunities for growth and capital deployment [9]
Digital Currency X Technology Inc. Regains Compliance with Nasdaq Bid Price Requirement and Hearing Cancelled
Globenewswire· 2026-02-20 13:15
Core Viewpoint - Digital Currency X Technology Inc. has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market [1][2]. Group 1: Compliance and Listing Status - The company received a notification from Nasdaq confirming compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) [1]. - A previously scheduled hearing on February 24, 2026, has been canceled due to the company's regained compliance [2]. - The company's securities will continue to be listed and traded on the Nasdaq Capital Market without interruption [2]. Group 2: Company Overview - Digital Currency X Technology Inc. is a pioneering digital asset treasury management company focused on secure cryptocurrency custody and storage solutions [3]. - The company is positioned at the forefront of institutional digital asset adoption and is executing a comprehensive digital currency strategy [3]. - Key components of the company's strategy include treasury optimization, participation in decentralized finance (DeFi) ecosystems, and development of advanced custody infrastructure [3].
No. 1/2026 - Financial calendar 2026/2027
Globenewswire· 2026-02-20 13:14
Financial Calendar - The financial calendar for 2026/2027 has been scheduled, detailing key reporting dates for the company [2] - The Annual Report for 2025 is set to be released on February 25, 2026 [2] - The Annual General Meeting for 2026 will take place on March 24, 2026 [2] - The Interim Report for the first half of 2026 is scheduled for August 26, 2026 [2] - The Annual Report for 2026 is planned for release on February 23, 2027 [2] - The Annual General Meeting for 2027 is set for March 18, 2027 [2]